BELLEVUE, WA / ACCESS Newswire / April 9, 2026 /OSR Holdings, Inc. (NASDAQ:OSRH) ("OSR Holdings" or the "Company") today announced a strategic transaction for capital structure optimization with White ...
Scorpio Tankers Inc. (NYSE: STNG) (the “Company”) announced today that it priced a private offering (the “Offering”) of $325 million aggregate principal amount of 1.75% convertible senior notes due ...
LOS ANGELES, CA / ACCESS Newswire / April 8, 2026 / Clean Vision Corporation (OCTQB:CLNV) ("Clean Vision" or the "Company"), ...
This is the second AI infrastructure contract Meta has signed with a value surpassing $20bn in one month. In March, Meta ...
LOS ANGELES, CA / ACCESS Newswire / April 8, 2026 / Clean Vision Corporation (OCTQB:CLNV) ("Clean Vision" or the "Company"), an emerging leader in innovative plastic conversion and clean fuel developm ...
Scorpio Tankers (STNG) announced pricing of a private offering of $325M of 1.75% convertible senior notes due in 2031. This amount is an increase from the initially planned $300M. The company also ...
S&P Global Ratings adjusted EBITDA margin declined to 74.9% in 2025 from 78.7% in 2024. CoreWeave recorded a free cash flow deficit of approximately $7.2 billion in 2025, funded primarily with debt. S ...
NEW YORK--(BUSINESS WIRE)--WisdomTree, Inc. (NYSE: WT) (“WisdomTree”), a global financial innovator, today announced its intention to offer, subject to market conditions and other factors, $525.0 ...
Think of AI as the new electricity — every hyperscaler needs more of it right now, or risk falling behind. Meta Platforms ...
Liberty Energy Inc. (NYSE: LBRT) (“Liberty”) today announced the pricing of, and that it has agreed to sell, $475.0 million aggregate principal amount of ...
InvestorsHub on MSN
Lumentum swaps $474.6 million in convertible notes for roughly 5.7 million shares
Lumentum Holdings Inc. (NASDAQ:LITE) said it has reached exchange agreements with certain holders of its convertible debt to ...
WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results